Article
Latest progress in molecular biology and treatment in genitourinary tumours.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Dec 2020
González-Del-Alba A, Arranz J Á, Bellmunt J, Maroto J P, Fernández-Calvo O, Valderrama B P, González-Billalabeitia E, Méndez-Vidal M J, Cassinello J, Romero-Laorden N, Climent M Á, Puente J, Peláez I, Lázaro-Quintela M, Gallardo E, Suárez C
Abstract excerpt
The management of genitourinary cancer, including bladder, prostate, renal and testicular cancer, has evolved dramatically in recent years due to a better understanding of tumour genetic mutations, alterations in molecular pathways, and to the development of new kinds of drugs such as targeted therapies and immunotherapies. In the field of immunotherapy, new drugs focused on stimulating, enhancing and modulating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.